Genomic and proteomic analysis of the myeloid differentiation program
Department of Pediatrics
Animals; Cell Differentiation; Cell Line; Electrophoresis, Gel, Two-Dimensional; Gene Expression Regulation; *Genomics; Mass Spectrometry; Mice; Myeloid Cells; Neutrophil Activation; Oligonucleotide Array Sequence Analysis; Proteins; Proteome; RNA, Messenger; Transduction, Genetic; Tretinoin
Hematology | Oncology | Pediatrics
Although the mature neutrophil is one of the better characterized mammalian cell types, the mechanisms of myeloid differentiation are incompletely understood at the molecular level. A mouse promyelocytic cell line (MPRO), derived from murine bone marrow cells and arrested developmentally by a dominant-negative retinoic acid receptor, morphologically differentiates to mature neutrophils in the presence of 10 microM retinoic acid. An extensive catalog was prepared of the gene expression changes that occur during morphologic maturation. To do this, 3'-end differential display, oligonucleotide chip array hybridization, and 2-dimensional protein electrophoresis were used. A large number of genes whose mRNA levels are modulated during differentiation of MPRO cells were identified. The results suggest the involvement of several transcription regulatory factors not previously implicated in this process, but they also emphasize the importance of events other than the production of new transcription factors. Furthermore, gene expression patterns were compared at the level of mRNA and protein, and the correlation between 2 parameters was studied. (Blood. 2001;98:513-524)
DOI of Published Version
Blood. 2001 Aug 1;98(3):513-24. doi 10.1182/blood.V98.3.513
Lian, Zheng; Wang, Le; Yamaga, Shigeru; Bonds, Wesley; Beazer-Barclay, Y.; Kluger, Yuval; Gerstein, Mark B.; Newburger, Peter E.; Berliner, Nancy; and Weissman, Sherman M., "Genomic and proteomic analysis of the myeloid differentiation program" (2001). Hematology/Oncology. 35.